123 Results

People

  1. Moore
    Moore
  2. Norton
    Norton
  3. Gabrilove
    Gabrilove
  4. Spriggs
    Spriggs
  5. Reich
    Reich
  6. Seidman
    Seidman
  7. Yao
    Yao
  8. Hudis
    Hudis
  9. Welte
    Welte
  10. Crown
    Crown

Groups

  1. Department of Medicine (62)
  2. Sloan Kettering Institute Faculty (38)
  3. Solid Tumor Oncology Division (36)
  4. Hematologic Malignancies, Division of (30)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (25)
  6. Cell Biology Program Faculty (24)
  7. Breast Medicine Service (20)
  8. Survivorship Research (20)
  9. Center for Hematologic Malignancies (19)
  10. Pediatrics, Department of (19)
  1. "granulocyte colony-stimulating factor"
Formats
  1. Journal Article (108)
  2. Conference Paper (8)
  3. Review (3)
  4. Meeting Abstract (2)
  5. Research Letter (2)
Groups
  1. Department of Medicine (62)
  2. Sloan Kettering Institute Faculty (38)
  3. Solid Tumor Oncology Division (36)
  4. Hematologic Malignancies, Division of (30)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (25)
  6. Cell Biology Program Faculty (24)

More Groups

People
  1. Malcolm Moore (24)
  2. Larry Norton (16)
  3. Janice Gabrilove (13)
  4. David Spriggs (10)
  5. Andrew Seidman (9)
  6. Lilian Reich (9)

More People

Years
  1. 2024 (4)
  2. 2023 (3)
  3. 2021 (2)
  4. 2020 (1)
  5. 2015 (1)
  6. 2014 (1)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Blood (10)
  3. Seminars in Oncology (9)
  4. JNCI: Journal of the National Cancer Institute (6)
  5. Cancer (5)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. Elsevier Inc. (18)
  2. American Society of Clinical Oncology (13)
  3. American Society of Hematology (10)
  4. Oxford University Press (10)
  5. American Association for Cancer Research (8)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (123)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production
    Journal Article

    Lin, H.; Cheung, S. W. Y.; Nesin, M.; Cassileth, B. R.; Cunningham Rundles, S.
    Clinical and Vaccine Immunology (2007)

    Fulltext@MSK | Save
  • Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer
    Journal Article

    Su, Y. B.; Vickers, A. J.; Zelefsky, M. J.; Kraus, D. H.; Shaha, A. R.; Shah, J. P.; Serio, A. M.; Harrison, L. B.; Bosl, G. J.; Pfister, D. G.
    The Cancer Journal (2006)

    Fulltext@MSK | Save
  • Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: A clinical and electrophysiologic study
    Journal Article

    Stubblefield, M. D.; Vahdat, L. T.; Balmaceda, C. M.; Troxel, A. B.; Hesdorffer, C. S.; Gooch, C. L.
    Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Ethnic disparities in adjuvant chemotherapy for breast cancer are not caused by excess toxicity in black patients
    Journal Article

    Smith, K.; Wray, L.; Klein-Cabral, M.; Schuchter, L.; Fox, K.; Glick, J.; DeMichele, A.
    Clinical Breast Cancer (2005)

    Fulltext@MSK | Save
  • Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: Report of a phase II trial
    Journal Article

    Gupta, S.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Reich, L.; Costello, S.; Drake, L.; Klimek, V.; Dhodapkar, M.; Teruya-Feldstein, J.; more...
    Bone Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Hematologic safety and tolerability of topotecan in recurrent ovarian cancer and small cell lung cancer: An integrated analysis
    Journal Article

    Armstrong, D. K.; Spriggs, D.; Levin, J.; Poulin, R.; Lane, S.
    The Oncologist (2005)

    Fulltext@MSK | Save
  • Dose-dense chemotherapy in breast cancer and lymphoma
    Journal Article

    Hudis, C. A.; Schmitz, N.
    Seminars in Oncology (2004)

    Fulltext@MSK | Save
  • Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer
    Journal Article

    Dang, C. T.; D'Andrea, G. M.; Moynahan, M. E.; Dickler, M. N.; Seidman, A. D.; Fornier, M.; Robson, M. E.; Theodoulou, M.; Lake, D.; Currie, V. E.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: A sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
    Journal Article

    Portlock, C. S.; Qin, J.; Schaindlin, P.; Roistacher, N.; Myers, J.; Filippa, D.; Louie, D.; Zelenetz, A. D.; O'Brien, J. P.; Moskowitz, C.; more...
    Annals of Oncology (2004)

    Fulltext@MSK | Save